These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12517880)

  • 1. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
    Espinel-Ingroff A
    J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.
    Fuller J; Schofield A; Jiwa S; Sand C; Jansen B; Rennie R
    J Clin Microbiol; 2010 Feb; 48(2):479-82. PubMed ID: 20007389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
    Martos AI; Romero A; González MT; González A; Serrano C; Castro C; Pemán J; Cantón E; Martín-Mazuelos E
    Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin].
    Ozkütük A; Metin DY; Ergon C; Yücesoy M; Hilmioğlu PS
    Mikrobiyol Bul; 2007 Apr; 41(2):285-90. PubMed ID: 17682716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
    Bartizal C; Odds FC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
    Imhof A; Balajee SA; Marr KA
    J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs.
    Pfaller MA; Messer SA; Mills K; Bolmström A
    J Clin Microbiol; 2000 Sep; 38(9):3359-61. PubMed ID: 10970383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
    Shalit I; Shadkchan Y; Samra Z; Osherov N
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study.
    Espinel-Ingroff A; Chaturvedi V; Fothergill A; Rinaldi MG
    J Clin Microbiol; 2002 Oct; 40(10):3776-81. PubMed ID: 12354880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2010 May; 67(1):56-60. PubMed ID: 20207095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
    Espinel-Ingroff A; Fothergill A; Fuller J; Johnson E; Pelaez T; Turnidge J
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2855-9. PubMed ID: 21422219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
    Pfaller JB; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
    J Clin Microbiol; 2003 Mar; 41(3):1126-9. PubMed ID: 12624040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2009 Oct; 47(10):3323-5. PubMed ID: 19710267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.